"10.1371_journal.pone.0016536","plos one","2011-01-31T00:00:00Z","Hanna Björkelund; Lars Gedda; Karl Andersson","Ridgeview Instruments AB, Uppsala, Sweden; Department of Oncology, Radiology and Clinical Immunology, Biomedical Radiation Sciences, Uppsala University, Uppsala, Sweden","Conceived and designed the experiments: HB KA. Performed the experiments: HB. Analyzed the data: HB LG KA. Contributed reagents/materials/analysis tools: LG KA. Wrote the paper: HB LG KA.","We have read the journal's policy and have the following conflicts: Ridgeview Instruments AB (RIAB) develops and sells the device LigandTracer, which is described in the manuscript. Hanna Björkelund and Karl Andersson are employed by RIAB. Karl Andersson is a shareholder of RIAB. RIAB acknowledges the adherence to all PLoS ONE policies on sharing data and materials. All equipment described in the report is commercially available, and no patents restrict the use of the described assays.","2011","01","Hanna Björkelund","HB",3,TRUE,2,1,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
